Web Desc
Neurodegeneration: The Biological Pathways Driving the Future of Therapeutic Development
joint with Neuro-Immune Interactions in the Central Nervous System
Scientific Organizers: Dimitri Krainc and Alfred W. Sandrock Jr.
Date: June 19 - 23, 2020
Location: Keystone Resort, Keystone, CO, USA
Sponsored by BioLegend, Inc., Roche and Ionis Pharmaceuticals, Inc.
Summary of Meeting:
Neurodegenerative diseases remain one of the main concerns for aging populations across the world. Elucidating the molecular mechanisms underlying these diseases thus remains a priority for developing effective therapeutics to combat them. Recent genetic studies linked to these diseases have pointed to functional defects in several key cellular organelles and pathways that appear to drive neurodegeneration, including endolysosomal, mitochondrial and synaptic dysfunctions. However, there is still much to be learned regarding the precise roles of these pathways in disease progression, their contribution to neuronal vulnerability, and how to effectively target these pathways in patients. Important mechanistic themes in neurodegenerative disease include the genetics of neuro-immune interactions, the involvement of synaptic molecular events, the role of endolysosomal, autophagic and mitochondrial dysfunction, the potential contribution of dynamic inter-organelle contact sites in neurons, and translational considerations including the use of biomarkers and gene therapy. The goal of this conference is to bring together fundamental basic scientists who are experts in these areas of cell biology, together with clinicians and medical researchers, and scientists investigating therapeutic strategies for neurodegeneration. By combining these different fields of expertise, this conference will stimulate cross-fertilization, in-depth interactions and insightful discussions on disease pathogenesis and strategies for advancing drug development for neurodegenerative disorders. Finally, this conference is being paired with a conference on Neuro-Immune Interactions in the Central Nervous System. This combination will be beneficial in that it will emphasize the crossover between neurodegeneration and neuroimmunology. As neuroimmunology is a recently reinvigorated field, this meeting will provide a critical opportunity to foster cross-disciplinary thinking.
DEADLINES:
*All deadlines end at 11:59 PM US Mountain Standard Time
Scholarship Deadline: February 18 2020 details
Discounted Abstract Deadline: February 18 2020 details & pricing
Abstract Deadline: March 17 2020 details & pricing
Discounted Registration Deadline: April 21 2020 details & pricing


Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.


Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.


Keystone Symposia thanks our Sponsor for generously supporting this meeting:
BioLegend, Inc.Ionis Pharmaceuticals, Inc.Roche
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found